In November 2018, Mayo Clinic Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Test
New tests launched in November 2018 by Mayo Clinic Laboratories:
-
- Cysticercosis Antibody, IgG, Serum (Mayo ID: CYSTS)
- Toxocara Antibody, IgG, Serum (Mayo ID: TOXOC)
- Rivaroxaban, Anti-Xa, Plasma (Mayo ID: RIVAR)
- Apixaban, Anti-Xa, Plasma (Mayo ID: APIXA)
- Epilepsy/Seizure Genetic Panels by Next-Generation Sequencing (NGS) (Mayo ID: ESPAN)
Test Updates
In addition to these new tests, the department also announced several test changes. Click the links below to view test changes announced via Mayo Clinic Laboratories:
